Live price temporarily unavailable.
Clarivate (CLVT) is a Industrials company in the Russell 2000. Latest news and coverage below.
Clarivate revenue & net income history (FY2017–FY2025)
| FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $917.6M | $968.5M | $974.3M | $1.25B | $1.88B | $2.66B | $2.63B | $2.56B | $2.46B |
| Growth (year over year) | — | +5.5% | +0.6% | +28.7% | +49.7% | +41.7% | −1.2% | −2.7% | −4.0% |
| Gross profit | — | — | $622.3M | $815.3M | $1.25B | $1.71B | $1.72B | $1.69B | $1.62B |
| Gross margin | — | — | 63.9% | 65.0% | 66.6% | 64.1% | 65.5% | 66.0% | 66.0% |
| Operating income | −$147.0M | −$105.7M | −$82.5M | −$36.3M | −$87.0M | −$3.93B | −$734.7M | −$275.6M | $71.5M |
| Operating margin | −16.0% | −10.9% | −8.5% | −2.9% | −4.6% | −147.6% | −27.9% | −10.8% | 2.9% |
| Net income | −$263.9M | −$242.2M | −$258.6M | −$350.6M | −$270.5M | −$3.96B | −$911.2M | −$636.7M | −$201.1M |
| Net margin | −28.8% | −25.0% | −26.5% | −28.0% | −14.4% | −148.9% | −34.7% | −24.9% | −8.2% |
| EPS (diluted) | −$160.83 | −$1.11 | −$0.94 | −$0.82 | −$0.61 | −$6.24 | −$1.47 | −$0.96 | −$0.30 |
| Balance sheet | |||||||||
| Cash and equivalents | $53.2M | $25.6M | $76.1M | $257.7M | $430.9M | $356.8M | $370.7M | $295.2M | $329.2M |
| Total assets | $4.01B | $3.71B | $3.79B | $14.8B | $20.2B | $13.9B | $12.7B | $11.5B | $11.1B |
| Total liabilities | $2.72B | $2.66B | $2.54B | $5.76B | $8.26B | $7.13B | $6.71B | $6.35B | $6.23B |
| Long-term debt | $1.97B | $1.93B | $1.63B | $3.46B | $5.46B | $5.00B | $4.72B | $4.52B | $4.32B |
| Shareholders' equity | $1.29B | $1.05B | $1.25B | $9.03B | $11.9B | $6.81B | $5.99B | $5.14B | $4.84B |
| Cash flow | |||||||||
| Operating cash flow | $6.67M | −$26.1M | $117.6M | $263.5M | $323.8M | $509.3M | $744.2M | $646.6M | $628.5M |
| Capital expenditure | $37.8M | $45.4M | $69.8M | $107.7M | $118.5M | $202.9M | $242.5M | $289.1M | $263.2M |
| Free cash flow | −$31.1M | −$71.5M | $47.7M | $155.8M | $205.3M | $306.4M | $501.7M | $357.5M | $365.3M |
| Dividends paid | — | — | — | $0 | $18.9M | $75.4M | $75.5M | $37.7M | $0 |
| Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $650.3M | $622.2M | $663.0M | $593.7M | $621.4M | $623.1M | $617.0M | $585.5M |
| Growth (year over year) | −2.8% | −3.9% | −3.0% | −4.4% | −4.4% | +0.1% | −6.9% | −1.4% |
| Gross profit | $436.7M | $412.1M | $435.3M | $386.7M | $417.8M | $404.9M | $412.2M | $393.4M |
| Gross margin | 67.2% | 66.2% | 65.7% | 65.1% | 67.2% | 65.0% | 66.8% | 67.2% |
| Operating income | −$240.0M | $21.7M | −$62.3M | −$20.8M | $6.90M | $44.0M | $41.4M | $30.2M |
| Operating margin | −36.9% | 3.5% | −9.4% | −3.5% | 1.1% | 7.1% | 6.7% | 5.2% |
| Net income | −$304.3M | −$65.6M | −$191.8M | −$103.9M | −$72.0M | −$28.3M | $3.10M | −$40.2M |
| Net margin | −46.8% | −10.5% | −28.9% | −17.5% | −11.6% | −4.5% | 0.5% | −6.9% |
| EPS (diluted) | −$0.46 | −$0.09 | −$0.27 | −$0.15 | −$0.11 | −$0.04 | $0.00 | −$0.06 |
| Balance sheet | ||||||||
| Cash and equivalents | $376.4M | $388.5M | $295.2M | $354.0M | $362.6M | $318.7M | $329.2M | $242.2M |
| Total assets | $12.1B | $12.0B | $11.5B | $11.5B | $11.4B | $11.2B | $11.1B | $10.9B |
| Total liabilities | $6.47B | $6.52B | $6.35B | $6.47B | $6.43B | $6.32B | $6.23B | $6.14B |
| Long-term debt | $4.64B | $4.63B | $4.52B | $4.52B | $4.52B | $4.42B | $4.32B | $4.28B |
| Shareholders' equity | $5.60B | $5.51B | $5.14B | $5.03B | $4.99B | $4.90B | $4.84B | $4.79B |
| Cash flow | ||||||||
| Operating cash flow | $126.2M | $202.9M | $141.3M | $171.2M | $116.3M | $181.1M | $159.9M | $134.7M |
| Capital expenditure | $65.9M | $76.6M | $82.2M | $60.9M | $66.0M | $65.6M | $70.7M | $55.8M |
| Free cash flow | $60.3M | $126.3M | $59.1M | $110.3M | $50.3M | $115.5M | $89.2M | $78.9M |
| Dividends paid | $18.8M | $0 | $0 | $0 | $0 | $0 | $0 | — |
From Clarivate's 10-K, 10-Q and 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Clarivate
Clarivate Plc (Clarivate) is a British-American publicly traded analytics company operating a collection of subscription-based services in the areas of bibliometrics and scientometrics, business and market intelligence, and competitive profiling for pharmacy and biotech, patents, regulatory compliance, trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals using data from its family of Web of Science products, including services and applications such as Publons, EndNote, and EndNote Click. Clarivate's other product families are Cortellis, Decision Resources Group (DRG), CPA Global, Derwent, CompuMark, Darts-ip, and ProQuest.
- Headquarters
- St. Helier, Jersey From SEC filings, Oct 2026
Recent News
No recent news mentioning Clarivate in our feed yet.
Other Industrials companies to compare with CLVT
- CECO Ceco Environmental Corp
- CHPT ChargePoint Holdings
- CIX Compx International Inc Class a
- CLH Clean Harbors
- CMCO Columbus Mckinnon Corp
- CMDB Costamare Bulkers Holdings LTD
- CMPR Cimpress PLC
- CMRE Costamare Inc